Quorum Health Corp (NYSE:QHC)’s share price gapped up prior to trading on Monday . The stock had previously closed at $4.78, but opened at $5.11. Quorum Health Corp shares last traded at $5.85, with a volume of 883,871 shares.

QHC has been the topic of a number of research analyst reports. Credit Suisse Group AG initiated coverage on Quorum Health Corp in a research note on Friday, July 29th. They issued a “neutral” rating and a $12.00 target price on the stock. Morgan Stanley restated a “hold” rating on shares of Quorum Health Corp in a research note on Thursday, August 11th. RBC Capital Markets restated a “sector perform” rating and issued a $6.00 target price (down previously from $13.00) on shares of Quorum Health Corp in a research note on Saturday. Mizuho initiated coverage on Quorum Health Corp in a research note on Monday, June 20th. They issued a “neutral” rating and a $11.25 target price on the stock. Finally, Royal Bank Of Canada began coverage on Quorum Health Corp in a research note on Thursday, June 2nd. They issued a “sector perform” rating and a $13.00 target price on the stock. Seven investment analysts have rated the stock with a hold rating, The stock currently has an average rating of “Hold” and a consensus price target of $10.54.

The company has a 50 day moving average price of $10.21 and a 200-day moving average price of $10.99. The company’s market cap is $173.68 million.

Quorum Health Corp (NYSE:QHC) last announced its earnings results on Wednesday, August 10th. The company reported ($8.63) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.11 by $8.74. The business had revenue of $529.70 million for the quarter, compared to analyst estimates of $564.19 million. The firm’s quarterly revenue was down 1.6% on a year-over-year basis. Equities analysts expect that Quorum Health Corp will post $0.52 earnings per share for the current fiscal year.

In other news, CEO Thomas Daniel Miller purchased 50,000 shares of the business’s stock in a transaction dated Wednesday, May 18th. The shares were purchased at an average price of $11.42 per share, for a total transaction of $571,000.00. Following the completion of the acquisition, the chief executive officer now directly owns 354,274 shares in the company, valued at approximately $4,045,809.08. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director James T. Breedlove purchased 20,000 shares of the business’s stock in a transaction dated Friday, May 20th. The shares were purchased at an average price of $11.92 per share, for a total transaction of $238,400.00. Following the acquisition, the director now owns 20,000 shares of the company’s stock, valued at $238,400. The disclosure for this purchase can be found here.

Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.